Pharma News

Tonix Pharmaceuticals Holding Corp. a company that is developing innovative pharmaceutical products to address public health challenges, announced it will present additional analyses of data from its Phase 2 study in military-related posttraumatic stress disorder, or PTSD, at the 72nd Annual Scientific Convention of the Society of Biological Psychiatry (SOBP) on May 20, 2017 in San Diego.

Medrobotics Corp., a medical robotics company, announced at the Royal Australasian College of Surgeons meeting in Adelaide that it has received TGA regulatory clearance to market the Flex® Robotic System for colorectal procedures. Medrobotics is the first and only company to offer minimally invasive, steerable and shapeable robotic products for colorectal procedures in Australia. The Flex® Robotic System is the world’s first robotic surgical platform to offer Scarfree™ access to hard-to-reach anatomy in otolaryngology and colorectal procedures. This provides surgeons treatment options that may not be possible with straight, rigid instruments.

Burcon NutraScience Corporation is pleased to announce that it has been granted a U.S. patent, covering technology for the production of its Peazazz® pea protein:  U.S. patent no. 9,635,875, was granted on May 2, 2017.  This patent is the first to be granted for Burcon’s pea technology by the United States Patent and Trademark Office and confirms that the Company’s approach is unique, distinct and defensible.  Burcon anticipates further positive progress, with its patent filings, in due course.

AstraZeneca and MedImmune, its global biologics research and development arm,  announced that tralokinumab, an anti-interleukin-13 (IL-13) human monoclonal antibody, did not meet its primary endpoint of a significant reduction in the annual asthma exacerbation rate (AAER) in the overall population of severe, uncontrolled asthma patients, compared with placebo in STRATOS 1, the first of two pivotal Phase III trials.

Torrent Pharma, announced that it has completed the acquisition of Regestrone and Pregachieve brands for India from global Pharma player Novartis AG, Switzerland.

Biocon's Bengaluru plant had inspected by USFDA between March 27 to April 7, 2017 and USFDA issued form no. 483 to Biocon, largest biotechnology company of India. USFDA observed total 8 issues which were shared with the company. Shares of Biocon fell down after this reports circulated in media.

In what may be a relief for more than 1 lakh thalassemia patients in India, a public-sector stem cell bank should report to King George's Medical University from here. A project of the university's transfusion medicine department, the stem cell bank will deploy stem cell therapy in patients with thalassemia and sickle cell anemia. The proposal is awaiting authorization from the State Department of Medical Education.

Cinnamon may lessen the risk of cardiovascular damage of a high-fat diet by activating the body's antioxidant and anti-inflammatory systems and slowing the fat-storing process, according to a preliminary animal study presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology | Peripheral Vascular Disease 2017 Scientific Sessions

A drug used to treat bipolar disorder and other forms of depression may help to preserve brain function and prevent nerve cells from dying in people with a traumatic brain injury, according to a new Rutgers University study.

Canadian physicians are being advised to reduce their prescribing of opioid medication to patients with chronic non-cancer pain in a new guideline for clinical care that focuses on harm reduction.